Collagen XV preserves heart function and protects from pathological remodelling after myocardial infarction

Sanna-Maria Karppinen1, Miki Aho1, Zoltan Szabo2,3

  • 1ECM-Hypoxia Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.

The FEBS Journal
|August 20, 2025
PubMed

Insights

Collagen XV (ColXV) is vital for heart structure and function after myocardial infarction (MI). Its absence leads to increased cardiac stiffness, impaired function, and adverse left ventricle remodeling following MI.

Area of Science:

  • Cardiovascular Biology
  • Extracellular Matrix Research
  • Myocardial Infarction Pathophysiology

Background:

  • Understanding left ventricle (LV) remodeling and fibrosis post-myocardial infarction (MI) is critical for heart pathology.
  • Collagen XV (ColXV) is implicated in cardiac tissue integrity.

Purpose of the Study:

  • To analyze ColXV expression in human myocardial infarcts.
  • To assess the impact of ColXV deficiency on cardiac responses after acute myocardial infarction (AMI) in mice, focusing on fibrogenesis and tissue stiffness.

Main Methods:

  • Human myocardial infarct samples were analyzed for ColXV expression.
  • Mice underwent LAD ligation for AMI induction.
  • Cardiac function and remodeling were assessed via echocardiography, elasticity measurements, immunohistochemistry, and ultrastructural analysis.

Main Results:

  • ColXV expression was high in human infarct scars.
  • Col15a1-/- mice exhibited increased LV stiffness, fibrosis-related gene upregulation, and disrupted scar ultrastructure post-AMI.
  • Knockout mice showed impaired cardiac function, reduced ejection fraction, and significant LV remodeling.

Conclusions:

  • ColXV is essential for maintaining cardiac structure and function after AMI.
  • ColXV deficiency results in dysregulated remodeling, a fragile scar, and a stiffer left ventricle, leading to a more severe cardiac phenotype.
  • These findings highlight ColXV's role in cardiac repair and suggest potential therapeutic implications for MI recovery.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K